Gut microbiota and obesity: lessons from the microbiome

Area of Science:

• Microbiology
• Metabolic Diseases
• Human Health

Background:

• The distal gut hosts a vast microbial community, outnumbering human eukaryotic cells.
• The gut microbiota's role in diseases such as obesity, type 2 diabetes, and inflammatory bowel diseases is increasingly recognized, though human causality requires further proof.
• Global alterations in gut microbiota composition are detectable via culture-dependent and independent methods.

Purpose of the Study:

• To review the association between specific gut microbial taxa and obesity.
• To discuss techniques for characterizing gut microbiota in the context of obesity and type 2 diabetes.
• To explore the interactions between gut microbiota and host metabolism.

Main Methods:

• 16S ribosomal RNA gene sequencing.
• DNA sequencing of whole-microbial communities.
• Culture-dependent and culture-independent microbiological methods.

Main Results:

• High-throughput sequencing facilitates the identification of novel candidate bacteria.
• Metabolic functions associated with obesity and type 2 diabetes are being identified.
• Associations between specific microbial taxa and obesity are being established.

Conclusions:

• Gut microbiota plays a crucial role in host metabolism.
• Understanding gut microbiota composition and function is key to addressing metabolic diseases.
• Further research is needed to establish causality between gut microbiota and human diseases.